Project Number 5R33NS106120-03 Agency/Funding Organization NINDS Funding Year 2022 View Full Project Details for Use of CRISPR/Cas9 to Treat Huntington Disease Research Categorization Primary Disease / Condition Frontotemporal Dementia CADRO Category H. Brain Aging and Common Mechanisms related to Dementia 2. Common Mechanisms Related to Dementias a. Basic Research Researcher and Organization Principal Investigator YAO, BING Principal Investigator First Name BING Principal Investigator Last Name YAO Awardee Organization EMORY UNIVERSITY Awardee State Georgia Contact PI Country United States Project Detail Funding Opportunity Announcement PAR-15-071: Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Pharmacodynamics and In vivo Efficacy Studies for Small Molecules and Biologics/Biotechnology Products (R21/R33) FY Overall Cost $387,507 Funding Organization Agency/Funding Organization NINDS Funding Organization Country United States Program Official ROOF, REBECCA
